EFG PH20 SC
ARGX-113-2007
Phase 3 mab active
Quick answer
EFG PH20 SC for Active Idiopathic Inflammatory Myopathy is a Phase 3 program (mab) at argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- argenx
- Indication
- Active Idiopathic Inflammatory Myopathy
- Phase
- Phase 3
- Modality
- mab
- Status
- active